genedrive plc (LSE: GDR) Stock Analysis & Fundamentals | ScreenerHero

Create free account

GDRgenedrive plc

LSE · GB · Healthcare · Diagnostics & Research · genedriveplc.com

1.300GBp0.00%Mkt Cap: 22.69M $P/E: —1d ago

genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The co…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

1M Perf

Avg

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap22.69M $

Enterprise Value14.67M $

Revenue (TTM)1.28M $

Gross Profit-3.62M $

Net Income (TTM)-5.69M $

Revenue/Share0.0022 USD

Last Price1.300 GBp

Fiscal Year EndJun 2025

MR QuarterDec 2025

Employees43

CountryGB

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)0.01

PEG—

EV/EBITDA-2.51

EV/Revenue11.50

P/S17.78

P/B—

EPS (TTM)-0.01

EPS (Forward)2.10

52W Range

0.190085% of range1.500

52W High1.500 GBp

52W Low0.1900 GBp

Profitability

Gross Margin-283.99%

Oper. Margin-459.47%

EBITDA Margin0.00%

Profit Margin-684.69%

ROE-363.77%

ROA-185.83%

Growth

Revenue Growth62.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-5.59M $

CapEx (TTM)25.00K $

FCF Margin-173.52%

FCF Yield-9.76%

Net Debt122.83K $

Net Debt/EBITDA-0.02

Balance Sheet

Debt/Equity0.00

Current Ratio0.99

Quick Ratio0.78

Book Value/Sh0.0000 GBp

Cash/Share0.0000 GBp

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 GBp

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.1.61B

Float561.10M

Insiders63.50%

Institutions1.31%

Technical

SMA 501.140 (+14.1%)

SMA 2000.9355 (+39.0%)

Beta1.02

S&P 52W Chg20.05%

Avg Vol (30d)5.93M

Avg Vol (10d)3.39M

Technical Indicators

RSI (14)60.2

MACD0.0403

MACD Signal0.0437

MACD Hist.-0.0034

BB Upper1.361 GBp

BB Middle1.268 GBp

BB Lower1.174 GBp

BB Width14.73%

ATR (14)0.1440 GBp

Vol Ratio (20d)0.65x